AEM vs IONR

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

IONR presents a profile of a pre-revenue development company with a Piotroski F-Score of 4/9, indicating stable but mediocre financial health. While the balance sheet is exceptionally clean with zero debt and a high current ratio (8.59), the company is suffering from extreme operational losses with an operating margin of -655.13%. The valuation is distorted by a Price/Sales ratio of 452.34, reflecting a near-total lack of revenue. Technical trends are completely bearish (0/100), and long-term price performance is deeply negative, suggesting the market is discounting the company's ability to reach production.